Tumoricidal effect and pain relief after concurrent therapy by strontium-89 chloride and zoledronic acid for bone metastases.
CONCLUSION: Concurrent therapy of 89SrCl2 with ZA may offer not only pain relief, but also a tumoricidal effect for painful bone metastases.
PMID: 29550842 [PubMed - as supplied by publisher]
Source: Hellenic Journal of Nuclear Medicine - Category: Nuclear Medicine Tags: Hell J Nucl Med Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chloride | Lung Cancer | Nuclear Medicine | Pain | Palliative | Prostate Cancer | Reclast | Study | Zometa